Delivery Order SPE2DB24D1104-SPE2DB24FYDJ3
Award Date
9/25/24
Potential Completion Date
9/26/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,793.57, is a delivery order for the supply of the pharmaceutical product APREPITANT 40 MG CAPSULE UD 5S. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,788.48, is for the supply of APREPITANT 40 MG CAPSULE UD 5S, a type of prescription medication. The contract has a firm fixed price pricing type and a completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,219.21 firm fixed-price delivery order is for APREPITANT 80 MG CAPSULE UD 6S, with a period of performance through January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,461.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. This award is not designated as a set-aside contract. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. AmerisourceBergen Drug Corp,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of APREPITANT 40 MG CAPSULE UDS, a pharmaceutical product, with a ceiling value of $1,171.95 and a completion date of May 24, 2024. The award is not associated with a set-aside program and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, has a single-award Indefinite Delivery...
This federal contract award, valued at $12,124.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4563971710 - APREPITANT 80 MG CAPSULE UU 2S, with a performance period ending on March 15, 2024. The contract is not designated as a set-aside and is awarded as a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a for-profit...
This federal contract award was issued by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,368.44 firm fixed price delivery order is for the supply of 40 mg Aprepitant capsules, which are a specialty pharmaceutical product used in medical treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of 4556527817 APREPITANT 80 MG CAPSULE UU 2S to the Defense Logistics Agency (DLA). The $3,531.50 firm fixed-price contract has a completion date of March 11, 2022. This delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
Amerisourcebergen Drug Corporation was awarded a $392 firm fixed price delivery order against an unidentified contract vehicle to supply 4562473188 APREPITANT 40 MG CAPSULES to the Defense Logistics Agency by October 16, 2023. The delivery order was awarded on October 13, 2023 without a set-aside designation by the Defense Logistics Agency out of their Conshohocken, Pennsylvania office. The Defense Logistics Agency supports America's armed forces by providing supplies in various operational...
This federal contract award, with an ID of SPE2DB22D1106 and SPE2DB24FEWZ0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a medication, with a ceiling value of $4,389.28 and a completion date of June 14, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...